Spectral Medical Inc
TSX:EDT

Watchlist Manager
Spectral Medical Inc Logo
Spectral Medical Inc
TSX:EDT
Watchlist
Price: 0.54 CAD -5.26% Market Closed
Market Cap: 152.7m CAD
Have any thoughts about
Spectral Medical Inc?
Write Note

Wall Street
Price Targets

EDT Price Targets Summary
Spectral Medical Inc

Wall Street analysts forecast EDT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EDT is 2.04 CAD with a low forecast of 2.02 CAD and a high forecast of 2.1 CAD.

Lowest
Price Target
2.02 CAD
274% Upside
Average
Price Target
2.04 CAD
278% Upside
Highest
Price Target
2.1 CAD
289% Upside
Spectral Medical Inc Competitors:
Price Targets
SGMO
Sangamo Therapeutics Inc
59% Upside
CAPR
Capricor Therapeutics Inc
131% Upside
ALKS
Alkermes Plc
22% Upside
SNDX
Syndax Pharmaceuticals Inc
117% Upside
BMRN
Biomarin Pharmaceutical Inc
55% Upside
MCRB
Seres Therapeutics Inc
573% Upside
EXEL
Exelixis Inc
14% Downside
STRO
Sutro Biopharma Inc
209% Upside

Revenue
Forecast

Revenue Estimate
Spectral Medical Inc

For the last 8 years the compound annual growth rate for Spectral Medical Inc's revenue is -8%. The projected CAGR for the next 2 years is 23%.

-8%
Past Growth
23%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Spectral Medical Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Spectral Medical Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EDT's stock price target?
Price Target
2.04 CAD

According to Wall Street analysts, the average 1-year price target for EDT is 2.04 CAD with a low forecast of 2.02 CAD and a high forecast of 2.1 CAD.

What is Spectral Medical Inc's Revenue forecast?
Projected CAGR
23%

For the last 8 years the compound annual growth rate for Spectral Medical Inc's revenue is -8%. The projected CAGR for the next 2 years is 23%.

Back to Top